querok
legrand pharma indÚstria farmacÊutica ltda - outros prods nao enquadrados em classe terapeutica especif
hemifumarato de quetiapina
aurobindo pharma indÚstria farmacÊutica limitada - hemifumarato de quetiapina - antipsicoticos
hemifumarato de quetiapina
cimed industria s.a - hemifumarato de quetiapina - antipsicoticos
hemifumarato de quetiapina
biolab sanus farmacÊutica ltda - hemifumarato de quetiapina - antipsicoticos
amalfi
eurofarma laboratÓrios s.a. - isotretinoÍna - produtos anti-acne
envid
biolab sanus farmacÊutica ltda - Ácido fÓlico, acetato de racealfatocoferol - vitaminas
sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - agentes antineoplásicos - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - agentes antineoplásicos - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
sunitinib tecnigen 25 mg cápsula
pentafarma - sociedade técnico-medicinal, s.a. - sunitinib - cápsula - 25 mg - sunitinib malato 33.4126 mg - sunitinib - genérico - duração do tratamento: longa duração
sunitinib bluepharma 37.5 mg cápsula
bluepharma genéricos - comércio de medicamentos s.a. - sunitinib - cápsula - 37.5 mg - cloridrato de sunitinib 40.939 mg - sunitinib - genérico - duração do tratamento: longa duração